SGCE encodes epsilon-sarcoglycan, a component of the sarcoglycan complex within the dystrophin-glycoprotein complex that links the F-actin cytoskeleton to the extracellular matrix 1. The gene contains multiple isoforms, including brain-specific variants, suggesting roles in central nervous system function beyond structural support 1. SGCE mutations cause myoclonus-dystonia (MD), an autosomal-dominant disorder with reduced penetrance and maternal imprinting 2. MD typically presents in early childhood with myoclonic jerks as the predominant symptom, accompanied by mild-to-moderate dystonia 3. Characteristic features include action-induced dystonia during writing and walking, with onset typically before age 25 3. Children with SGCE-MD display recognizable dystonic patterns including writer's cramp and distinctive gait abnormalities, with many utilizing sensory tricks to manage symptoms 4. Clinically, SGCE-related hyperkinesia presents with generalized hyperkinetic movements and earlier disease onset compared to focal forms 5. Deep brain stimulation of the globus pallidus internus effectively treats SGCE-related dystonia 5. The exact pathogenic mechanisms remain unknown, though altered synaptic functioning is hypothesized 1. Genetic testing can confirm diagnosis in most patients, enabling early intervention and genetic counseling 5.